SPY
736.53
+0.17%
QQQ
657.50
+0.21%
BTC/USD
75,260.10
−0.64%
DIA
512.52
+0.06%
GLD
373.37
+0.23%
TLT
81.85
−0.09%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Globe Newswire
Articles by Globe Newswire
FireFly’s drilling results extend high-grade core zone laterally
The latest results, such as 16.4m @ 9.2% CuEq and 15.5m @ 12.4% CuEq , are significant due to the potential impact of the up-dip mineralisation on the upcoming Feasibility Study mine plan and economics KEY POINTS
IMP761 Late-Breaking Abstract at ACR Convergence 2026 Highlights Statistically Significant & Exposure-Dependent Inhibition of T-Cell-Driven Immune Responses
Statistically significant and exposure-dependent inhibition of T-cell-driven immune responses in healthy volunteers, with greater pharmacodynamic effects at higher IMP761 exposureWell tolerated across all seven dose
INVESTOR ALERT: RGRD Law Announces that D-Wave Quantum Inc. (QBTS) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit
SAN DIEGO, Nov. 08, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of D-Wave Quantum Inc. (NASDAQ:QBTS) securities between February 26, 2026 and
Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026
– In the largest long-term hypertension trial of an aldosterone synthase inhibitor to date, lorundrostat demonstrated sustained reduction in automated office systolic blood pressure (AOSBP) of 17.8 mmHg at Week 48 from
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
Total Company Revenue increased 22.1% to $638.3 million in the third quarter of 2026 from $522.9 million in the third quarter of 2025; Revenue from the Digital Health reportable segment (inclusive of intersegment
CIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD
Single administration of CIDEBsiRNA resulted in rapid, deep and durable reductions in liver fat by up to 80% that were sustained through 36 weeks Data from first-in-human trial were shared in oral presentation at AASLD
National Association of REALTORS® Announces Approval of Four MLS Policy Recommendations at NAR NXT™ 2026
Chicago, Nov. 08, 2026 (GLOBE NEWSWIRE) -- The National Association of REALTORS®’ (NAR’s) Multiple Listing Issues and Policies Committee today proposed four MLS policy recommendations which were considered and adopted
MONDAY PANEL: Afghan SIV Security Threat – Vetting Failures and the Need for Action
Washington, D.C., Nov. 08, 2026 (GLOBE NEWSWIRE) -- Afghan SIV Security Threat: Vetting Failures and the Need for Action Date: Monday, November 9 Time: 3:00 p.m. ET Location: Bellator Hall, 213
AVITA Medical to Host Investor Webinar Briefing
VALENCIA, Calif., Nov. 08, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical," or the "Company"), a leading therapeutic acute wound care company delivering
Statement from NVIDIA Board of Directors
The NVIDIA Board is initiating an independent investigation in light of recent reporting that founder and CEO Jensen Huang has been the target of a foreign intelligence effort. A committee of independent directors,
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Coastal Financial Corporation (NASDAQ: CCB) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Lead Plaintiff Deadline: December 1, 2026. Investors who purchased (NASDAQ:CCB) securities between October 28, 2024 and July 29, 2026 may be eligible to recover losses. NEW YORK, Nov. 08, 2026 (GLOBE NEWSWIRE) --
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Honeywell Aerospace, Inc. (NASDAQ: HONA) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Lead Plaintiff Deadline: November 23, 2026. Investors who purchased (NASDAQ:HONA) securities between June 29, 2026 and September 1, 2026 may be eligible to recover losses. NEW YORK, Nov. 08, 2026 (GLOBE NEWSWIRE) --
Six AGIBOT G2 Robots Complete 1,730 Tasks in 24-Hour Shanghai Convenience Store Trial
Shanghai, Nov. 08, 2026 (GLOBE NEWSWIRE) -- Six AGIBOT G2 wheeled humanoid robots completed a 24-hour trial at an operating convenience store in Shanghai's Xuhui District, performing a combined 1,730 tasks ranging
Gildan Activewear Inc. (GIL) Investor Alert: GIL Stock Drops Further Amid Poor Q3 Earnings; December 14, 2026 Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Did you buy GIL securities between February 19, 2025 and June 15, 2026? Affected GIL Investor Summary Who: Gildan Activewear Inc. (NYSE:GIL)What: Securities fraud class action lawsuit filedClass Period: February 19,
CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
Systemic sclerosis (SSc) data presented at ACR Convergence 2026 showed 83% (5/6) of patients receiving standard lymphodepletion achieved a clinical response (rCRISS-25) at Month 3, with all responders maintaining
Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026
Clinically meaningful improvement in disease activity among 8 of 9 evaluable patients, including rapid and marked reductions in proteinuria with complete renal responses Deep and sustained reduction in pathogenic
BETR DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Better Home & Finance Holding Company Investors to Secure Counsel Before Important November 20 Deadline in Securities Class Action - BETR
NEW YORK, Nov. 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Better Home & Finance Holding Company (NASDAQ:BETR) between March 13, 2026
Colin Kaepernick honored as Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards
LOUISVILLE, Ky., Nov. 08, 2026 (GLOBE NEWSWIRE) -- The Muhammad Ali Center hosted its 13th annual Muhammad Ali Humanitarian Awards on Saturday, November 7 at the Ali Center in Louisville, Kentucky. The Center’s
Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases
100% (6 of 6) of dermatomyositis patients maintained immunomodulator-free, moderate-to-major TIS responses through one year, with most patients also free of steroids 100% (5 of 5) of lupus nephritis patients with
Hollywood & Sports Royalty Show Up for the Global Down Syndrome Foundation Fashion Show
DENVER, CO, Nov. 08, 2026 (GLOBE NEWSWIRE) -- Grammy and Emmy Award-winning entertainer and global superstar Justin Timberlake shared the runway with his niece, Zaya Biel, at the Global Down Syndrome Foundation's
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Every Story That Matters Around The Web
I Thought I Needed $1M To Retire Until I Ran The Numbers. Now I'm Wondering If It's Really This Simple It Almost Seems Too Good To Be True
Bill Gates Says A $10-an-Hour Robot Could Replace The $20-an-Hour Worker – 'There Is No Plan' For What Comes Next
Peter Schiff, Ted Cruz and Rand Paul Sound Warnings as Oil, AI and Debt Rattle Markets: This Week in Economics
I Stopped Filing My Taxes In 2014 And Have Been Living In Fear Ever Since. After 22 Years As A Truck Driver, I Don't Know How To Fix This
SanDisk Stock Drops Ahead of Split as Wall Street Analysts Weigh In - SanDisk (NASDAQ:SNDK) - Benzinga
Nvidia Stock Loses Key Support, Enters Bear Market as Earnings Loom